Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13120036 | 0.92 | HTR6 (0.66) | HTR6BCHE | |
| Trifluoroacetic Acid SCHEMBL5923799 | 0.86 | HTR6 (0.64) | HTR6BCHE | |
| Trifluoroacetic Acid SCHEMBL3623224 | 0.85 | HTR6 (0.58) | HTR6BCHE | |
| Trifluoroacetic Acid SCHEMBL4019045 | 0.84 | HTR6 (0.57) | HTR6BCHE | |
| Trifluoroacetic Acid SCHEMBL3615520 | 0.83 | HTR6 (0.67) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3623759 | 0.82 | HTR6 (0.54) | HTR6BCHE | |
| SCHEMBL31668258 | 0.80 | HTR6 (0.62) | HTR6BCHE | |
| Trifluoroacetic Acid SCHEMBL3621161 | 0.79 | HTR6 (0.65) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL4021334 | 0.79 | HTR6 (0.58) | HTR6BCHE | |
| Trifluoroacetic Acid SCHEMBL4019041 | 0.78 | HTR6 (0.82) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046741-B1 | INDOLES AS 5-HT6 MODULATORS | PROXIMAGEN LTD (GB) | 2012-10-31 | — | — | EP | disclosed |
| US-7812017-B2 | 4-substituted indole and indoline compounds | BIOVITRUM AB (PUBL.) (SE) | 2010-10-12 | — | — | US | disclosed |
| US-20080032968-A1 | New compounds | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2008-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080032968-A1 | New compounds | HTR6, HTR1B, HTR1A | HTR6 1/4885BCHE 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.